Tricyclic Pyrazoles. 4. Synthesis and Biological Evaluation of Analogues of the Robust and Selective CB2 Cannabinoid Ligand 1-(2‘,4‘-Dichlorophenyl)-6-methyl-N-piperidin-1-yl- 1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide
New analogues (2a−p) of the previously reported CB2 ligands 6-methyl- and 6-chloro-1-(2‘,4‘-dichlorophenyl)-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamides (1a,b) have been synthesized and evaluated for cannabinoid receptor affinity. One example, 1-(2‘,4‘-dichlorophenyl)-6-methyl-N-...
Saved in:
Published in | Journal of medicinal chemistry Vol. 49; no. 25; pp. 7502 - 7512 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
WASHINGTON
American Chemical Society
14.12.2006
Amer Chemical Soc |
Subjects | |
Online Access | Get full text |
ISSN | 0022-2623 1520-4804 |
DOI | 10.1021/jm060920d |
Cover
Abstract | New analogues (2a−p) of the previously reported CB2 ligands 6-methyl- and 6-chloro-1-(2‘,4‘-dichlorophenyl)-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamides (1a,b) have been synthesized and evaluated for cannabinoid receptor affinity. One example, 1-(2‘,4‘-dichlorophenyl)-6-methyl-N-cyclohexyilamine-1,4-dihydroindeno[1,2-c] pyrazole-3-carboxamide (2a) was shown to have single digit nanomolar affinity for cannabinoid CB2 receptors. Furthermore, compounds 2a and 2b, as well as lead structures 1a,b, were also shown to be agonist in an in vitro model based on human promyelocytic leukemia HL-60 cells. |
---|---|
AbstractList | New analogues (2a-p) of the previously reported CB2 ligands 6-methyl- and 6-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamides (1a,b) have been synthesized and evaluated for cannabinoid receptor affinity. One example, 1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexyilamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide (2a) was shown to have single digit nanomolar affinity for cannabinoid CB2 receptors. Furthermore, compounds 2a and 2b, as well as lead structures 1a, b, were also shown to be agonist in an in vitro model based on human promyelocytic leukemia HL-60 cells. New analogues (2a−p) of the previously reported CB2 ligands 6-methyl- and 6-chloro-1-(2‘,4‘-dichlorophenyl)-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamides (1a,b) have been synthesized and evaluated for cannabinoid receptor affinity. One example, 1-(2‘,4‘-dichlorophenyl)-6-methyl-N-cyclohexyilamine-1,4-dihydroindeno[1,2-c] pyrazole-3-carboxamide (2a) was shown to have single digit nanomolar affinity for cannabinoid CB2 receptors. Furthermore, compounds 2a and 2b, as well as lead structures 1a,b, were also shown to be agonist in an in vitro model based on human promyelocytic leukemia HL-60 cells. New analogues (2a-p) of the previously reported CB(2) ligands 6-methyl- and 6-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamides (1a,b) have been synthesized and evaluated for cannabinoid receptor affinity. One example, 1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexyilamine-1,4-dihydroindeno[1,2-c] pyrazole-3-carboxamide (2a) was shown to have single digit nanomolar affinity for cannabinoid CB(2) receptors. Furthermore, compounds 2a and 2b, as well as lead structures 1a,b, were also shown to be agonist in an in vitro model based on human promyelocytic leukemia HL-60 cells. |
Author | Loriga, Giovanni Pinna, Gérard A Lazzari, Paolo Chelucci, Giorgio Falzoi, Matteo Manca, Ilaria Murineddu, Gabriele Sanna, Angela Curzu, Maria M Dessì, Christian Pani, Luca Ruiu, Stefania |
Author_xml | – sequence: 1 givenname: Gabriele surname: Murineddu fullname: Murineddu, Gabriele – sequence: 2 givenname: Paolo surname: Lazzari fullname: Lazzari, Paolo – sequence: 3 givenname: Stefania surname: Ruiu fullname: Ruiu, Stefania – sequence: 4 givenname: Angela surname: Sanna fullname: Sanna, Angela – sequence: 5 givenname: Giovanni surname: Loriga fullname: Loriga, Giovanni – sequence: 6 givenname: Ilaria surname: Manca fullname: Manca, Ilaria – sequence: 7 givenname: Matteo surname: Falzoi fullname: Falzoi, Matteo – sequence: 8 givenname: Christian surname: Dessì fullname: Dessì, Christian – sequence: 9 givenname: Maria M surname: Curzu fullname: Curzu, Maria M – sequence: 10 givenname: Giorgio surname: Chelucci fullname: Chelucci, Giorgio – sequence: 11 givenname: Luca surname: Pani fullname: Pani, Luca – sequence: 12 givenname: Gérard A surname: Pinna fullname: Pinna, Gérard A |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18352558$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17149879$$D View this record in MEDLINE/PubMed |
BookMark | eNqNks9u1DAQxiNURLeFAy-AfEECsV5sJ86fYxtaQFpB1V1UCYSiie10vSR2FCel4cRj8Hx9ErzdZXvl4rE9v2-kmW-OggNjjQqC55TMKGH07bohMckYkY-CCeWM4Cgl0UEwIYQxzGIWHgZHzq0JISFl4ZPgkCY0ytIkmwR3y06LUdRaoIuxg1-2Vm6GohlajKZfKacdAiPRqba1vdYCanR2A_UAvbYG2QqdGPCJQbnNwwvQpS0H19-LFqpWotc3CuWnDOVgDJTaWC3RXF9vAIpfsbvff6aRP_A7LVa17Wy7UmasX-MYN6pfjTX-hFvdqk5LbTDF_gPRaYSlXo2ys9pIZew3OmVYfG93HeAQC-hKewuNlupp8LiC2qlnu3gcfDk_W-Yf8Pzz-4_5yRwDI3GPS5AipbJKuGQyC0FVQCCqIiIzlRDIyghiIsK4LGWSpoJXPFGM0jiL44ynUIbHwYtt3XYoGyWLttMNdGPxb9geeLkDwPlJVh0Yod0Dl4accZ56Lt1yP1VpKye0MkLtMe8ii7ypPN3ceK77ezNyO5jeS9_8v9TTeEtr16vbPQbdjyJOwoQXy4tFkZ3z8Cu9uiyuHhoA4Yq1HTpvvisoKTZbWOy3MPwLx2vOig |
CODEN | JMCMAR |
Cites_doi | 10.1111/j.1460-9568.2006.04684.x 10.1073/pnas.1834309100 10.1016/j.brainres.2005.11.035 10.1038/sj.bjp.0706406 10.1002/syn.20050 10.1182/blood-2002-01-0098 10.1124/jpet.103.049924 10.1038/sj.ijo.0803272 10.1016/S0306-4522(03)00126-X 10.1016/j.brainres.2005.04.053 10.1093/jb/mvh063 |
ContentType | Journal Article |
Copyright | Copyright © 2006 American Chemical Society 2007 INIST-CNRS |
Copyright_xml | – notice: Copyright © 2006 American Chemical Society – notice: 2007 INIST-CNRS |
DBID | BSCLL 17B 1KM BLEPL DTL EGQ GAHYA IQODW CGR CUY CVF ECM EIF NPM |
DOI | 10.1021/jm060920d |
DatabaseName | Istex Web of Knowledge Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science Primary (SCIE, SSCI & AHCI) Web of Science - Science Citation Index Expanded - 2006 Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | Web of Science MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | Web of Science MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1520-4804 |
EndPage | 7512 |
ExternalDocumentID | 17149879 18352558 000242625800025 ark_67375_TPS_9F53Z1WR_W b169805992 |
Genre | Journal Article |
GroupedDBID | - .K2 4.4 53G 55A 5GY 5RE 5VS 7~N AABXI ABFLS ABMVS ABOCM ABPTK ABUCX ACGFS ACJ ACS AEESW AENEX AFEFF AFFNX ALMA_UNASSIGNED_HOLDINGS ANTXH AQSVZ BAANH CS3 DU5 EBS ED ED~ EJD F5P GJ GNL IH9 IHE JG JG~ K2 L7B LG6 NHB P2P ROL TN5 UI2 VF5 VG9 W1F WH7 X XFK YZZ ZY4 --- -~X .GJ AAHBH AAYOK ABJNI ABQRX ABTAH ACGFO ADHLV AGXLV AHGAQ BSCLL CUPRZ GGK IH2 XSW YQT 17B 1KM ABBLG ABLBI ACRPL ADNMO AEYZD AGQPQ ANPPW BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED GROUPED_WOS_WEB_OF_SCIENCE .55 .HR 1KJ 1WB 3EH 3O- 6P2 6TJ 9M8 ABHMW ADXHL IQODW MVM OHT RNS UBC X7M ZE2 ZGI CGR CUY CVF ECM EIF NPM VXZ YIN |
ID | FETCH-LOGICAL-a206t-badc81df75d2d93aefa0a4f40d9e70a9b4a60c36bbd788c5f57e2116966958ab3 |
IEDL.DBID | ACS |
ISICitedReferencesCount | 67 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000242625800025 |
ISSN | 0022-2623 |
IngestDate | Wed Feb 19 01:47:24 EST 2025 Mon Jul 21 09:13:25 EDT 2025 Wed Aug 06 08:05:30 EDT 2025 Fri Sep 26 20:46:22 EDT 2025 Wed Oct 30 09:29:37 EDT 2024 Thu Aug 27 13:42:08 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 25 |
Keywords | SR 144528 2-ARACHIDONOYLGLYCEROL ACTIVATION ANTAGONIST PHARMACOLOGY INVOLVEMENT INVERSE AGONIST MICROGLIAL CELLS EXPRESSION RECEPTOR CB2 Human Promyelocytic leukemia Ligand CB2 cannabinoid receptor Selectivity Tricyclic compound In vitro HL60 cell line Cell line Structure activity relation Piperidine derivatives Carboxamide Chemical synthesis Tumor cell |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-a206t-badc81df75d2d93aefa0a4f40d9e70a9b4a60c36bbd788c5f57e2116966958ab3 |
Notes | istex:63D4E0AA0E9D71C9E3CA9EC451EA23E0317E4DC1 ark:/67375/TPS-9F53Z1WR-W |
ORCID | 0000-0003-4215-6399 0000-0001-6390-3811 0000-0001-9273-2839 0000-0003-3043-3387 |
PMID | 17149879 |
PageCount | 11 |
ParticipantIDs | pubmed_primary_17149879 webofscience_primary_000242625800025CitationCount acs_journals_10_1021_jm060920d pascalfrancis_primary_18352558 webofscience_primary_000242625800025 istex_primary_ark_67375_TPS_9F53Z1WR_W |
ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N ACJ VG9 W1F ANTXH ACS AEESW AFEFF .K2 ABMVS ABUCX IH9 BAANH AQSVZ ED~ UI2 |
PublicationCentury | 2000 |
PublicationDate | 2006-12-14 |
PublicationDateYYYYMMDD | 2006-12-14 |
PublicationDate_xml | – month: 12 year: 2006 text: 2006-12-14 day: 14 |
PublicationDecade | 2000 |
PublicationPlace | WASHINGTON |
PublicationPlace_xml | – name: WASHINGTON – name: Washington, DC – name: United States |
PublicationTitle | Journal of medicinal chemistry |
PublicationTitleAbbrev | J MED CHEM |
PublicationTitleAlternate | J. Med. Chem |
PublicationYear | 2006 |
Publisher | American Chemical Society Amer Chemical Soc |
Publisher_xml | – name: American Chemical Society – name: Amer Chemical Soc |
References | Jbilo, O (WOS:000079782900016) 1999; 448 Raitio, KH (WOS:000228824700005) 2005; 12 Casu, MA (WOS:000230259600005) 2005; 1048 McKallip, RJ (WOS:000176741200033) 2002; 100 Casu, MA (WOS:000180303900011) 2003; 459 HART, RT (WOS:A1950UB71100100) 1950; 72 Kishimoto, S (WOS:000221224100009) 2004; 135 Derocq, JM (WOS:000087291400005) 2000; 275 Gong, JP (WOS:000236014600002) 2006; 1071 Rinaldi-Carmona, M (WOS:000071929100030) 1998; 284 Pertwee, RG (WOS:000168900100027) 2001; 48 (WOS:000242625800025.1) 2001 Benito, C (WOS:000187228500017) 2003; 23 Lange, JHM (WOS:000228845100008) 2005; 10 Bouaboula, M (WOS:000081438300057) 1999; 274 BRADFORD, MM (WOS:A1976BU74400029) 1976; 72 Nunez, E (WOS:000223197100003) 2004; 53 Howlett, AC (WOS:000175879600002) 2002; 54 Nackley, AG (WOS:000183755700014) 2003; 119 McAllister, SD (WOS:000177113300006) 2002; 63 Porcella, A (WOS:000178743600014) 2002; 147 Portier, M (WOS:000078286700026) 1999; 288 Pertwee, RG (WOS:000236709500004) 2006; 30 Ibrahim, MM (WOS:000185119300071) 2003; 100 Hanus, L (WOS:000084149700019) 1999; 96 Porcella, A (WOS:000086258700037) 2000; 12 Glass, M (WOS:000168312100005) 2001; 25 Mussinu, JM (WOS:000179819400009) 2003; 11 CHENG, Y (WOS:A1973R295300018) 1973; 22 Ruiu, S (WOS:000183613200044) 2003; 306 Bouaboula, M (WOS:A1997XT85000096) 1997; 272 MUNRO, S (WOS:A1993LV64600054) 1993; 365 Lu, QJ (WOS:000085927000009) 2000; 17 Beltramo, M (WOS:000236176000013) 2006; 23 Sugiura, T (WOS:000226008300004) 2004; 96 Clayton, N (WOS:000175758400005) 2002; 96 Pertwee, RG (WOS:000235087400020) 2006; 147 Carrier, EJ (WOS:000220450200022) 2004; 65 Do, Y (WOS:000223208900022) 2004; 173 Pertwee, RG (WOS:A1997XM74100001) 1997; 74 Reggio, PH (WOS:000184562100003) 2003; 9 |
References_xml | – volume: 74 start-page: 129 year: 1997 ident: WOS:A1997XM74100001 article-title: Pharmacology of cannabinoid CB1 and CB2 receptors publication-title: PHARMACOLOGY & THERAPEUTICS – volume: 63 start-page: 2121 year: 2002 ident: WOS:000177113300006 article-title: A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognition publication-title: BIOCHEMICAL PHARMACOLOGY – volume: 72 start-page: 3286 year: 1950 ident: WOS:A1950UB71100100 article-title: ACYLATION ALKYLATION STUDIES .1. publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY – volume: 23 start-page: 1530 year: 2006 ident: WOS:000236176000013 article-title: CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms publication-title: EUROPEAN JOURNAL OF NEUROSCIENCE doi: 10.1111/j.1460-9568.2006.04684.x – volume: 100 start-page: 10529 year: 2003 ident: WOS:000185119300071 article-title: Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA doi: 10.1073/pnas.1834309100 – volume: 147 start-page: 255 year: 2002 ident: WOS:000178743600014 article-title: Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid publication-title: EUROPEAN JOURNAL OF ENDOCRINOLOGY – volume: 11 start-page: 251 year: 2003 ident: WOS:000179819400009 article-title: Tricyclic pyrazoles. part 1: Synthesis and biological evaluation of novel 1,4-dihydroindeno[1,2-c]pyrazol-based ligands for CB1 and CB2 cannabinoid receptors publication-title: BIOORGANIC & MEDICINAL CHEMISTRY – volume: 65 start-page: 999 year: 2004 ident: WOS:000220450200022 article-title: Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism publication-title: MOLECULAR PHARMACOLOGY – volume: 1071 start-page: 10 year: 2006 ident: WOS:000236014600002 article-title: Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain publication-title: BRAIN RESEARCH doi: 10.1016/j.brainres.2005.11.035 – volume: 23 start-page: 11136 year: 2003 ident: WOS:000187228500017 article-title: Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains publication-title: JOURNAL OF NEUROSCIENCE – volume: 12 start-page: 1217 year: 2005 ident: WOS:000228824700005 article-title: Targeting the cannabinoid CB2 receptor: Mutations, modeling and development of CB2 selective ligands publication-title: CURRENT MEDICINAL CHEMISTRY – volume: 173 start-page: 2373 year: 2004 ident: WOS:000223208900022 article-title: Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappa B-dependent apoptosis: Novel role for endogenous and exogenous cannabinoids in immunoregulation publication-title: JOURNAL OF IMMUNOLOGY – volume: 147 start-page: S163 year: 2006 ident: WOS:000235087400020 article-title: Cannabinoid pharmacology: the first 66 years publication-title: BRITISH JOURNAL OF PHARMACOLOGY doi: 10.1038/sj.bjp.0706406 – volume: 288 start-page: 582 year: 1999 ident: WOS:000078286700026 article-title: SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist publication-title: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS – volume: 12 start-page: 1123 year: 2000 ident: WOS:000086258700037 article-title: The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein publication-title: EUROPEAN JOURNAL OF NEUROSCIENCE – volume: 284 start-page: 644 year: 1998 ident: WOS:000071929100030 article-title: SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor publication-title: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS – volume: 275 start-page: 15621 year: 2000 ident: WOS:000087291400005 article-title: Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60 - Possible involvement of the CB2 receptor in cell differentiation publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY – volume: 48 start-page: 859 year: 2001 ident: WOS:000168900100027 article-title: Cannabinoids and the gastrointestinal tract publication-title: GUT – volume: 53 start-page: 208 year: 2004 ident: WOS:000223197100003 article-title: Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study publication-title: SYNAPSE doi: 10.1002/syn.20050 – volume: 100 start-page: 627 year: 2002 ident: WOS:000176741200033 article-title: Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease publication-title: BLOOD doi: 10.1182/blood-2002-01-0098 – volume: 17 start-page: 91 year: 2000 ident: WOS:000085927000009 article-title: Expression of CB2 cannabinoid receptor mRNA in adult rat retina publication-title: VISUAL NEUROSCIENCE – volume: 96 start-page: 367 year: 2004 ident: WOS:000226008300004 article-title: New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation publication-title: JOURNAL OF PHARMACOLOGICAL SCIENCES – volume: 448 start-page: 273 year: 1999 ident: WOS:000079782900016 article-title: Stimulation of peripheral cannabinoid receptor CB2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL60 publication-title: FEBS LETTERS – volume: 9 start-page: 1607 year: 2003 ident: WOS:000184562100003 article-title: Pharmacophores for ligand recognition and activation/inactivation of the cannabinoid receptors publication-title: CURRENT PHARMACEUTICAL DESIGN – volume: 22 start-page: 3099 year: 1973 ident: WOS:A1973R295300018 article-title: RELATIONSHIP BETWEEN INHIBITION CONSTANT (K1) AND CONCENTRATION OF INHIBITOR WHICH CAUSES 50 PER CENT INHIBITION (I50) OF AN ENZYMATIC-REACTION publication-title: BIOCHEMICAL PHARMACOLOGY – volume: 96 start-page: 253 year: 2002 ident: WOS:000175758400005 article-title: CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain publication-title: PAIN – volume: 306 start-page: 363 year: 2003 ident: WOS:000183613200044 article-title: Synthesis and characterization of NESS 0327: A novel putative antagonist of the CB1 cannabinoid receptor publication-title: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS doi: 10.1124/jpet.103.049924 – volume: 10 start-page: 693 year: 2005 ident: WOS:000228845100008 article-title: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists publication-title: DRUG DISCOVERY TODAY – volume: 459 start-page: 97 year: 2003 ident: WOS:000180303900011 article-title: Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract publication-title: EUROPEAN JOURNAL OF PHARMACOLOGY – volume: 30 start-page: S13 year: 2006 ident: WOS:000236709500004 article-title: The pharmacology of cannabinoid receptors and their ligands: an overview publication-title: INTERNATIONAL JOURNAL OF OBESITY doi: 10.1038/sj.ijo.0803272 – volume: 119 start-page: 747 year: 2003 ident: WOS:000183755700014 article-title: Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation publication-title: NEUROSCIENCE doi: 10.1016/S0306-4522(03)00126-X – volume: 1048 start-page: 41 year: 2005 ident: WOS:000230259600005 article-title: Effect of Delta(9)-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: An immunohistochemical study publication-title: BRAIN RESEARCH doi: 10.1016/j.brainres.2005.04.053 – volume: 96 start-page: 14228 year: 1999 ident: WOS:000084149700019 article-title: HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA – year: 2001 ident: WOS:000242625800025.1 – volume: 365 start-page: 61 year: 1993 ident: WOS:A1993LV64600054 article-title: MOLECULAR CHARACTERIZATION OF A PERIPHERAL RECEPTOR FOR CANNABINOIDS publication-title: NATURE – volume: 274 start-page: 20397 year: 1999 ident: WOS:000081438300057 article-title: Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528 - Implications for receptor biological responses publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY – volume: 135 start-page: 517 year: 2004 ident: WOS:000221224100009 article-title: 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells publication-title: JOURNAL OF BIOCHEMISTRY doi: 10.1093/jb/mvh063 – volume: 54 start-page: 161 year: 2002 ident: WOS:000175879600002 article-title: International Union of Pharmacology. XXVII. Classification of cannabinoid receptors publication-title: PHARMACOLOGICAL REVIEWS – volume: 272 start-page: 22330 year: 1997 ident: WOS:A1997XT85000096 article-title: A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 - Evidence for a new model of receptor/ligand interactions publication-title: JOURNAL OF BIOLOGICAL CHEMISTRY – volume: 72 start-page: 248 year: 1976 ident: WOS:A1976BU74400029 article-title: RAPID AND SENSITIVE METHOD FOR QUANTITATION OF MICROGRAM QUANTITIES OF PROTEIN UTILIZING PRINCIPLE OF PROTEIN-DYE BINDING publication-title: ANALYTICAL BIOCHEMISTRY – volume: 25 start-page: 743 year: 2001 ident: WOS:000168312100005 article-title: The role of cannabinoids in neurodegenerative diseases publication-title: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY |
SSID | ssj0003123 |
Score | 2.137389 |
Snippet | New analogues (2a−p) of the previously reported CB2 ligands 6-methyl- and... New analogues (2a-p) of the previously reported CB2 ligands 6-methyl- and... New analogues (2a-p) of the previously reported CB(2) ligands 6-methyl- and... |
Source | Web of Science |
SourceID | pubmed pascalfrancis webofscience istex acs |
SourceType | Index Database Enrichment Source Publisher |
StartPage | 7502 |
SubjectTerms | Biological and medical sciences Chemistry, Medicinal HL-60 Cells Humans Indenes - chemical synthesis Indenes - chemistry Indenes - pharmacology Life Sciences & Biomedicine Ligands Medical sciences Miscellaneous Mitogen-Activated Protein Kinase 1 - biosynthesis Mitogen-Activated Protein Kinase 3 - biosynthesis Neuropharmacology Neurotransmitters. Neurotransmission. Receptors Pharmacology & Pharmacy Pharmacology. Drug treatments Phosphorylation Piperidines - chemical synthesis Piperidines - chemistry Piperidines - pharmacology Pyrazoles - chemical synthesis Pyrazoles - chemistry Pyrazoles - pharmacology Radioligand Assay Receptor, Cannabinoid, CB2 - agonists Science & Technology Structure-Activity Relationship |
Title | Tricyclic Pyrazoles. 4. Synthesis and Biological Evaluation of Analogues of the Robust and Selective CB2 Cannabinoid Ligand 1-(2‘,4‘-Dichlorophenyl)-6-methyl-N-piperidin-1-yl- 1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide |
URI | http://dx.doi.org/10.1021/jm060920d https://api.istex.fr/ark:/67375/TPS-9F53Z1WR-W/fulltext.pdf http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000242625800025 https://www.ncbi.nlm.nih.gov/pubmed/17149879 |
Volume | 49 |
WOS | 000242625800025 |
WOSCitedRecordID | wos000242625800025 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLbGeIAXLuNWLpMlpgmkuiSO7TSPkK2aEEzV2mkTaIp8SVhYl1RJKy174mfw-_ZLOE7SdggxeImS2I5k-9jn-2L7OwhtgVdnQSIcQqUWBBA4JxIYGGFKJjpxfOUJezj5877YO2Qfj_nxGnr9lxV86r77fu4IJ6COuYVuUwH-xeKfcLScbj2XegtJcArOfCEfdL2odT26BPxpm-7C7n-UJTRB0sSuuNn51I5mcB_tLI7rNPtLznrzmerpyz_VG2-qwwN0rwWa-H1jGQ_RWpxtoDvhIr7bBtoeNqrVVRePV4ewyi7exsOVnnX1CF2NYa6s9CTVeFgV8tJKQPUw6-FRlQF8LNMSy8zgJqql7XO8u5QQx3mCre6J_UFU2gcogA9yNS9ndaFRHYYHZlwcfqA4lFkmgarnqcGf0m82g0ve0KsfP7sMLmQn1aeTvLBSCFk1eUsEsQGwqwnZJ9PUSjaDIwayCi-w22XEpKeVKXIrCJnlX90uJfpk2taAeETLQuUX8jw18WN0ONgdh3ukDQ1BJHXEjChpNCDtxOeGmsCTcSIdyRLmmCD2HRkoJoWjPaGUAY6vecL9GKiuAHIX8L5U3hO0nuVZ_AxhXwuVKB17vlGMKYCghvaBVnqJUgB-ZQdtgu1E7dAuo3rVngJrWvRpB23XZhVNG32QSBZndrucz6PxcBQFA-59cY8OoiP40m92tyzgWhjMeb-DnjaGuErxgcH2_aCDtq5b5jLdaTAW5X17xzvI_Z9sYSv_bmUPZs__Vb8X6C5tozW57CVanxXz-BUgsZnarEfiLzZtL10 |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwGLVgPIwXLuNWLsMPUwVSXRLHdprHUVYV2Kpq7bQJhCJfEhbWJVXTSsue-Bn8vv0SPidpO3iAvUS52YqTL_7OSexzENqBrM6CWDiESi0IIHBOJDAwwpSMdez4yhN2cvLBQPSP2KcTflLL5Ni5MHAROdSUlz_x1-oC7rsf545wAuqY2-gOF0xYm4bd7mjV63ou9ZbK4BRy-lJF6HpRm4F0DjDU3sELOwxS5nAn4srC4t85qMw3vfuVcVF5peUwk7P2Yq7a-vIvEcebNeUBulfDTrxbxclDdCtKt9Bmd-n2toWaw0rDumjh8XpKVt7CTTxcq1sXj9DVGHrOQk8SjYfFTF5aQag2Zm08KlIAk3mSY5kaXHlc2gjAeytBcZzF2Kqg2M9Fud2AAvgwU4t8XhYalaY80P_i7nuKuzJNJRD3LDF4P_luT3DJG3r181eLwYJ8SPTpJJtZYYS0mLwlglg77GJCBmSaWAFnSMtAXWEHdluMmOS0MLPMykOm2Ve3RYn-Nq1bQDyi5UxlF_I8MdFjdNTbG3f7pDaKIJI6Yk6UNBpwd-xzQ03gySiWjmQxc0wQ-Y4MFJPC0Z5QygDj1zzmfgTEVwDVC3hHKu8J2kizNHqGsK-FipWOPN8oxhQAUkM7QDK9WCmAwrKBtuGRhvWLnoflP3wKHGr5TBuoWUZXOK3UQkI5O7OD53wejoejMOhx74t7fBgeQ01_hN-qgGtBMeedBnpaxeP6iA98tuMHDbRzPUBXx50KcVHesWu8gdybnNatxeCtCML8-f_a9xpt9scH--H-x8HnF-gurX2cXPYSbcxni-gVYLS52i5fzt9ZJje_ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZgSMALl3Erl-GHqQKpLokTJ83jyFYNGKVaO20aQpEvMQvrkipppWVP_Ax-334Jx0naDh5gL1ES50RxfOzzfYn9HYQ2Iaq7gfYsQrn0CCBwRjgwMOIKrqW2fOF4ZnHy54G3e-B-PGJHDVE0a2HgIQq4U1H9xDe9eqp0ozBgv_txZnlWQC11E90CIGKbVA1b4Wg58jo2dRbq4BTi-kJJ6KqpiUKyAChq3uK5mQrJC3gbuk5j8e84VMWc_n30Zfm01VST0-58Jrry4i8hx-tX5wG618BPvFX7y0N0I07X0Z1wkfVtHbWHtZZ12cHj1dKsooPbeLhSuS4focsxjKClnCQSD8ucXxhhqC52u3hUpgAqi6TAPFW4znVpPAHvLIXFcaaxUUMxn40KcwAGeD8T82JWGY2q5DwwDuPwPcUhT1MOBD5LFN5LvpsLbPKGXv781XFhQ7YTeTLJciOQkJaTt8QjJi12OSEDMk2MkDOEZ6CwcALbHZeo5KRUeWZkItPsq92hRH6bNjUgDpE8F9k5P0tU_Bgd9HfG4S5pEkYQTi1vRgRXEvC39pmiKnB4rLnFXe1aKoh9iwfC5Z4lHU8IBcxfMs38GAiwB5QvYD0unCdoLc3S-BnCvvSEFjJ2fCVcVwAwVbQHZNPRQgAk5i20Ac0aNR2-iKp_-RS41KJNW6hdeVg0rVVDIp6fmkl0PovGw1EU9JlzbB_uR4dwpz9ccGlgG3DMWK-FntY-uSrxgdf2_KCFNq866bLcqpEXZT2zx1rIvs5lYSMKb8QQZs__V7_X6PZwux_tfRh8eoHu0iadk-2-RGuzfB6_Aqg2ExtV__wNH1o6OQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tricyclic+pyrazoles.+4.+Synthesis+and+biological+evaluation+of+analogues+of+the+robust+and+selective+CB2+cannabinoid+ligand+1-%282%27%2C4%27-dichlorophenyl%29-6-methyl-N-piperidin-1-yl-1%2C4+-dihydroindeno%5B1%2C2+-c+%5Dpyrazole-3-carboxamide&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=MURINEDDU%2C+Gabriele&rft.au=LAZZARI%2C+Paolo&rft.au=PANI%2C+Luca&rft.au=PINNA%2C+G%C3%A9rard+A&rft.date=2006-12-14&rft.pub=American+Chemical+Society&rft.issn=0022-2623&rft.volume=49&rft.issue=25&rft.spage=7502&rft.epage=7512&rft_id=info:doi/10.1021%2Fjm060920d&rft.externalDBID=n%2Fa&rft.externalDocID=18352558 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon |